Pivotal trial of AVXS 101 in patients with spinal muscular atrophy type 1

Trial Profile

Pivotal trial of AVXS 101 in patients with spinal muscular atrophy type 1

Planning
Phase of Trial: Phase III

Latest Information Update: 16 Jan 2018

At a glance

  • Drugs AVXS 101 (Primary)
  • Indications Spinal muscular atrophy
  • Focus Registrational; Therapeutic Use
  • Acronyms STR1VE EU
  • Most Recent Events

    • 16 Jan 2018 Planned initiation date changed from 1 Jan 2017 to 1 Jan 2018, according to Avexis media release.
    • 16 Jan 2018 According to Avexis media release, this trial may expects to start in the first half of 2018. European Medicines Agency helped to design a protocol of this trial.
    • 08 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top